NCT05799521View on ClinicalTrials.gov

A Nasal Treatment for COVID-19

PHASE2RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 27, 2023

Primary Completion Date

March 30, 2026

Study Completion Date

March 30, 2026

Conditions

COVID-19

Interventions

DRUG

Optate

Alkaline Buffer

DRUG

Placebo

Normal Saline

Trial Locations (1)

46202

RECRUITING

Riley Hospital for Children, Indianapolis

All Listed Sponsors

lead

Indiana University

OTHER